Expression of 16 kDa proteolipid of vacuolar-type H+-ATPase in human pancreatic cancer
1996

V-ATPase Expression in Human Pancreatic Cancer

Sample size: 49 publication Evidence: moderate

Author Information

Author(s): T Ohta, M Numata, H Yagishita, F Futagami, Y Tsukioka, H Kitagawa, M Kayahara, T Nagakawa, I Miyazaki, M Yamamoto, S Iseki, S Ohkuma

Primary Institution: Kanazawa University

Hypothesis

Human pancreatic cancers might overexpress V-ATPase in the endomembrane system and possibly in the plasma membrane.

Conclusion

The overexpression of V-ATPase protein is characteristic of invasive pancreatic tumors and may play crucial roles in tumor progression.

Supporting Evidence

  • 42 out of 46 invasive ductal cancers displayed mild to marked immunoreactivity for V-ATPase.
  • There was a notable difference in the level of V-ATPase mRNA between normal and pancreatic carcinoma tissues.
  • V-ATPase may play crucial roles in tumor progression.

Takeaway

This study found that a specific protein, V-ATPase, is found in high amounts in aggressive pancreatic cancer cells, which might help the cancer grow.

Methodology

The study used RT-PCR to analyze mRNA levels and immunohistochemistry to assess protein levels in pancreatic cancer tissues.

Limitations

It was difficult to obtain total RNAs from non-cancerous tissues, which may affect the comparison.

Participant Demographics

The study included 49 patients with pancreatic ductal adenocarcinomas, consisting of 30 men and 19 women, aged 33 to 78 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication